Today: 7 February 2026
Subscribe
Browse Category

Cannabis Industry News 23 November 2025 - 9 January 2026

Tilray Brands (TLRY) stock jumps in premarket after record $218 mln quarter and net cash turn

Tilray Brands (TLRY) stock jumps in premarket after record $218 mln quarter and net cash turn

Tilray shares jumped nearly 9% to $9.95 in premarket trading after reporting fiscal Q2 revenue of $217.5 million and a narrowed net loss of $43.5 million. The company reaffirmed its full-year adjusted profit target and said it moved to a net cash position. Gross margin slipped, and craft beer sales remained under pressure. Traders are watching if the gains hold at the open.
9 January 2026
··
Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth Corporation (NASDAQ: CGC, TSX: WEED) is ending 2025 with something cannabis stocks haven’t seen in a while: sustained, headline-driven volatility — the kind that can lift prices fast, then yank them back down just as quickly. As of Dec. 24, 2025, CGC was trading around $1.40 in U.S. markets, after closing at $1.40 on Dec. 23 and showing a modest uptick in early premarket indications. StockAnalysis That price tag doesn’t tell the story by itself. December’s story is about policy momentum in Washington, a fresh Canadian acquisition announcement, and a market that’s still trying to decide whether Canopy
24 December 2025
····
Tilray Brands (TLRY) Stock News Today: Cannabis Rescheduling, Earnings Date, Reverse Split, and Analyst Forecasts (Dec. 24, 2025)

Tilray Brands (TLRY) Stock News Today: Cannabis Rescheduling, Earnings Date, Reverse Split, and Analyst Forecasts (Dec. 24, 2025)

Tilray Brands, Inc. (NASDAQ: TLRY) has spent December doing what cannabis stocks do best: moving fast, arguing loudly with gravity, and reacting to headlines like they’re caffeine. As of Wednesday, December 24, 2025, TLRY is trading around $10.53. The reason investors keep refreshing their screens is simple: U.S. federal cannabis policy may be shifting in a meaningful (but not instantly transformative) way. President Donald Trump signed an executive order on December 18, 2025 directing the process to reclassify marijuana from Schedule I to Schedule III, a move that could eventually reduce tax burdens and ease certain business constraints across the
24 December 2025
··
Canada Stock Market Today: TSX Slips at Midday as Financials Weigh, While Cannabis and Commodities Stay in Focus (Dec. 17, 2025)

Canada Stock Market Today: TSX Slips at Midday as Financials Weigh, While Cannabis and Commodities Stay in Focus (Dec. 17, 2025)

Canada’s stock market is struggling to hold early momentum on Wednesday as the heavyweight financial sector drags on the Toronto Stock Exchange, even while commodity-linked and cannabis stocks remain in the spotlight. By late morning, the S&P/TSX Composite Index had moved into negative territory after earlier edging higher on a rebound in oil and a fresh surge in precious metals. CityNews Halifax+1 The midday picture is being shaped by three dominant forces: (1) renewed caution in global equities as U.S. tech and AI names pressure Wall Street, (2) sharp moves in energy and metals prices after U.S. President Donald Trump ordered
17 December 2025
··
Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025)

Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025)

Tilray Brands, Inc. (NASDAQ: TLRY) stock is back in the spotlight on December 17, 2025, as cannabis stocks react—again—to fast-moving headlines around potential U.S. federal marijuana rescheduling. In the latest session, TLRY traded around $13.94, up roughly 27% on the day, after swinging between about $10.32 and $14.54—a reminder that Tilray remains one of the market’s most headline-sensitive, momentum-driven names. So what changed this time? A cluster of reports and follow-on commentary about President Donald Trump and a possible executive order aimed at reclassifying marijuana—paired with the stock’s own structural catalysts (notably its recent 1-for-10 reverse split)—is amplifying both upside
17 December 2025
···
S&P/TSX Composite Today: Oil Slips Toward $60, Cannabis Surges, and Macklem’s Speech Looms for After-the-Bell Trade (Dec. 16, 2025)

S&P/TSX Composite Today: Oil Slips Toward $60, Cannabis Surges, and Macklem’s Speech Looms for After-the-Bell Trade (Dec. 16, 2025)

Canada’s S&P/TSX Composite index was lower in late-morning trading Tuesday, weighed down by a sharp slide in energy names as crude prices weakened on renewed optimism around Russia–Ukraine peace talks. At around 11:26 a.m. ET, the benchmark was about 31,324 points, down roughly 0.5% on a delayed quote—putting the TSX on pace for a third straight daily decline, even after a powerful 2025 run that has left the index up about 26.7% year to date. MarketScreener+1 With the closing bell still hours away (4:00 p.m. ET), investors are navigating a market that is increasingly headline- and data-driven—with fresh U.S. macro numbers landing today, commodities resetting lower, and Bank of Canada Governor Tiff
16 December 2025
··
Tilray Brands (TLRY) Stock News Today: Cannabis Rally Cools as Trump Schedule III Speculation Fuels Volatility

Tilray Brands (TLRY) Stock News Today: Cannabis Rally Cools as Trump Schedule III Speculation Fuels Volatility

December 15, 2025 Tilray Brands, Inc. (NASDAQ: TLRY) is back in the spotlight on December 15 after one of its biggest momentum bursts in years—followed by an equally fast reality check. The stock’s latest swing is being driven less by quarterly fundamentals and more by a single macro catalyst: growing (but still unconfirmed) expectations that President Donald Trump could move to ease federal marijuana restrictions by pushing a reclassification of cannabis to Schedule III. That policy headline helped ignite a sector-wide surge late last week. On Monday, however, the rally showed clear signs of fatigue as uncertainty over timing, scope,
15 December 2025
··
Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Brands (TLRY) is back at the center of the cannabis market’s biggest catalyst in years: growing expectations that President Donald Trump could move to ease federal marijuana restrictions by pushing a reclassification of cannabis to Schedule III. On Monday, December 15, 2025, the optimism spilled into global trading, with cannabis names extending last week’s explosive rally as investors tried to price what a Schedule III world could mean for taxes, banking access, and institutional participation. Reuters+1 But Tilray’s move isn’t just about Washington. The company is also coming off a 1-for-10 reverse stock split and fresh product momentum tied
15 December 2025
····
Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)

Canopy Growth Corporation stock is back in the spotlight on December 15, 2025, as the cannabis sector reacts to a fresh wave of reporting that President Donald Trump may soon move to ease federal marijuana restrictions—specifically by reclassifying cannabis as a Schedule III drug under U.S. law. In early European trading on Monday, Canopy Growth led the group, jumping as much as 17.9% and extending a dramatic rally from the prior session. Reuters For investors, traders, and anyone trying to separate “real policy catalyst” from “market caffeine,” the key story today is simple: CGC is moving hard because U.S. federal
15 December 2025
··
Tilray Brands (TLRY) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025

Tilray Brands (TLRY) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025

Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) is back in the spotlight heading into Monday’s U.S. market open (Dec. 15, 2025) after a policy-driven surge that reminded investors why cannabis-linked equities can move fast—often on headlines more than fundamentals. In Friday’s regular session (Dec. 12), TLRY closed at $12.15, up about 44% on the day, after trading in a wide $10.32–$13.85 range on ~84.2 million shares. Nasdaq Here’s what matters most before the bell: the federal-policy catalyst behind the move, the “post–reverse split” reality that can distort charts and targets, what Tilray’s latest financials say about the business today, and
14 December 2025
···
Tilray Brands (TLRY) Stock Jumps on Marijuana Rescheduling Buzz: This Week’s Move, Latest News, and Week-Ahead Outlook (Updated Dec. 12, 2025)

Tilray Brands (TLRY) Stock Jumps on Marijuana Rescheduling Buzz: This Week’s Move, Latest News, and Week-Ahead Outlook (Updated Dec. 12, 2025)

Updated: Friday, Dec. 12, 2025 (after U.S. market close)Meta description: Tilray (TLRY) surged this week as cannabis stocks spiked on reports Trump may push marijuana rescheduling. Here’s what happened and what to watch next week. Tilray Brands, Inc. (NASDAQ: TLRY) delivered one of the cannabis sector’s most dramatic weekly moves, culminating in a surge on Friday, December 12, as traders reacted to fresh reporting that President Donald Trump could soon take steps aimed at loosening federal marijuana restrictions. By the close on Dec. 12, TLRY finished at $12.15, up 44.13% on the day, after trading between $10.28 and $12.41. Volume
13 December 2025
··
Top Stock Gainers Today (Dec. 12, 2025, 12:30 p.m. ET): cbdMD, Canopy Growth, Tilray Lead a Cannabis-Fueled Rally

Top Stock Gainers Today (Dec. 12, 2025, 12:30 p.m. ET): cbdMD, Canopy Growth, Tilray Lead a Cannabis-Fueled Rally

Here are the biggest US stock market gainers at midday on Dec. 12, 2025—plus what’s driving the moves, from cannabis policy headlines to earnings reports and SEC filings. StockAnalysis+2Reuters+2 At 12:30 p.m. ET on Friday, December 12, 2025, the US stock market is showing a familiar split screen: broad indexes are lower, led by weakness in tech and semiconductors, while a handful of headline-driven pockets—especially cannabis-related names and a few earnings movers—are posting outsized gains. On a percentage basis across US-listed stocks, many of the day’s top gainers are small-cap and micro-cap companies, where relatively modest flows (and, at times, trading halts or low liquidity) can translate
12 December 2025
····
Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

December 12, 2025 — Cronos Group Inc. (NASDAQ: CRON , TSX: CRON ) is back in the spotlight after cannabis stocks jumped broadly into early trading on reports that the Trump administration could pursue a major easing of federal marijuana restrictions — specifically, a push to reclassify marijuana from Schedule I to Schedule III .Reuters+ 1 For Cronos investors, today’s move is not happening in a vacuum. The stock entered December with fresh momentum after the company announced a strategic acquisition in the Netherlands , a deal that management says would give Cronos the #1 market share within Europe’s largest
12 December 2025
··
Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)

Canopy Growth Corporation stock (NASDAQ: CGC ; TSX: WEED ) is in the spotlight on Friday, December 12, 2025 , after a fresh wave of US federal policy speculation sent cannabis names sharply higher in premarket trading. The immediate catalyst: a report that President Donald Trump is expected to push for a major easing of federal marijuana restrictions—specifically, directing agencies to reclassify marijuana as a Schedule III drug . That headline quickly rippled through US-listed cannabis stocks, with Canopy Growth among the notable movers.Reuters+ 1 Below is a detailed round-up of today’s key news , today’s market reaction , and
12 December 2025
····
Tilray Brands (TLRY) Stock Jumps on Trump Marijuana Rescheduling Report: Latest News, Forecasts, and Analyst Views (Dec. 12, 2025)

Tilray Brands (TLRY) Stock Jumps on Trump Marijuana Rescheduling Report: Latest News, Forecasts, and Analyst Views (Dec. 12, 2025)

Tilray Brands (NASDAQ: TLRY) is surging as cannabis stocks rally on fresh U.S. rescheduling headlines. Here’s what’s driving TLRY, what analysts forecast, and what to watch next. Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) is back in the spotlight on Friday, December 12, 2025, after a sharp move higher in extended-hours trading and premarket action alongside a broader rally in cannabis-linked equities. The immediate catalyst is political: a report that President Donald Trump is expected to push the federal government to loosen marijuana restrictions by directing agencies toward reclassifying marijuana as a Schedule III substance—a shift that could materially change
12 December 2025
···
US Stock Market Premarket Top Gainers Today (Dec. 12, 2025): Lululemon Surges, Cannabis Stocks Rally, Mitek and Quanex Jump

US Stock Market Premarket Top Gainers Today (Dec. 12, 2025): Lululemon Surges, Cannabis Stocks Rally, Mitek and Quanex Jump

Updated: Friday, December 12, 2025 — 6:00 a.m. ET SEO summary: Here are the biggest US stock market premarket gainers today (NYSE/Nasdaq) and the news driving them, including Lululemon’s earnings and CEO transition, a cannabis-stock surge tied to marijuana rescheduling headlines, and earnings-driven jumps in Mitek and Quanex. Nasdaq+4StockAnalysis+4Reuters+4 US stock futures were mixed early Friday, with investors balancing a post-Fed backdrop against renewed questions around big-tech AI spending after Oracle’s latest move and broader positioning into year-end. Reuters Below is a detailed look at the top premarket gainers as of about 6:00 a.m. ET, plus the headlines, forecasts, and analyst takes circulating on 12/12/2025. Top premarket stock gainers right now (as of ~6:00 a.m. ET) These are the leading percentage gainers in
12 December 2025
·············
Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

Tilray Brands (TLRY) Soars After Reverse Stock Split and Cannabis Bill Hopes: Stock Forecast, Price Targets and 2026 Outlook

As of December 10, 2025 Tilray stock rebounds 12% after brutal selling Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) just reminded investors how violently cannabis stocks can move. On Tuesday, December 9, 2025, TLRY jumped about 12.4% to close around $8.09, sharply outperforming a flat broader market. Trading volume topped 8.6 million shares, above the 50‑day average of roughly 7.8 million. Even after that rally, Tilray’s share price is still about 65% below its 52‑week high of $23.20, reached on October 9. MarketWatch+1 The surge followed weeks of heavy selling. On December 3, the stock fell 8.4% to $7.06, marking
10 December 2025
···
Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis Inc. (NASDAQ: ACB; TSX: ACB) is ending 2025 in a very different place from where it started. After years of restructuring, the company has become a highly focused global medical cannabis business, with new partnerships in Australia, expanding operations in Europe, and back‑to‑back quarters of record medical revenue. As of the latest trading sessions before December 7, 2025, ACB’s U.S.-listed shares trade around US$4.60, while the TSX listing changes hands near C$6.39, giving the company a market value in roughly the US$260–280 million range. Investing.com+2Stock Titan+2 Here’s a deep dive into the latest news, earnings, forecasts and analyses
7 December 2025
··
Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround

December 6, 2025 Canopy Growth Stock Snapshot as of December 6, 2025 Canopy Growth Corp (NASDAQ: CGC, TSX: WEED) remains one of the most volatile names in global cannabis — and 2025 has been no exception. In other words, CGC is bouncing off its lows but still priced like a distressed turnaround. Q2 FY2026 Earnings: Margins Improve, Losses Narrow Canopy’s second quarter of fiscal 2026 (three months ended September 30, 2025) was the first real proof that its years‑long restructuring might be gaining traction. According to the company’s official earnings release and independent summaries: Canopy Growth+1 Fintool’s recap notes that,
6 December 2025
··
Tilray Stock Today, November 23, 2025: TLRY Under $1 as AI Trading Signals, Hemp Rules and Big Holders Collide

Tilray Stock Today, November 23, 2025: TLRY Under $1 as AI Trading Signals, Hemp Rules and Big Holders Collide

Tilray Brands stock (NASDAQ: TLRY; TSX: TLRY) is back in the spotlight this Sunday, November 23, 2025, for all the reasons that make cannabis names both fascinating and stressful to follow:the share price has slipped back under $1, new AI-driven trading plans dropped this morning, a fresh “millionaire maker” think-piece is circulating, and regulators are pulling the sector in opposite directions. Here’s a full breakdown of everything new on Tilray today, plus the key numbers, fundamentals, and risks traders are weighing right now. Tilray stock price snapshot for November 23, 2025 Because U.S. markets are closed today (Sunday), the latest
23 November 2025
··
1 2

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Go toTop